ABC294640 in Treating Patients With Advanced Solid Tumors

NCT01488513 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: sphingosine kinase-2 inhibitor ABC294640

Sponsor

RedHill Biopharma Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]